Accurate assessment of dietary intake remains a fundamental challenge in nutritional epidemiology (1,7). Conventional self-reported instruments, including food-frequency questionnaires and dietary recalls, are vulnerable to systematic and random measurement error, potentially attenuating associations between diet and chronic disease outcomes (7,8). Dietary biomarkers—objective molecular indicators measured in biological specimens—offer a promising strategy to enhance exposure assessment (1,2). Advances in metabolomics and high-resolution analytical platforms have facilitated the identification and validation of candidate biomarkers across major food groups, including dairy, meat, fish, cereals, fruits, and vegetables (1,14).
Validation frameworks emphasize biological plausibility, food specificity, biospecimen selection, analytical robustness, correlation with habitual intake, pharmacokinetic characterization, reproducibility over time, and dose–response relationships (3,25). Among established biomarkers, plasma odd-chain fatty acids reflect dairy fat intake (31–34); acetylcarnitine and 3-methylhistidine are associated with meat consumption (10,19); eicosapentaenoic acid and docosahexaenoic acid robustly indicate fish intake (13,20); alkylresorcinols serve as reliable markers of whole-grain wheat and rye (11,18); and proline betaine and carotenoids reflect citrus and vegetable consumption, respectively (4,14). Nevertheless, many biomarkers lack complete specificity, and concentrations may be influenced by interindividual metabolic variability, gut microbiota composition, renal function, and genetic factors (1,7).
Emerging multi-biomarker panels and systems-based approaches integrating metabolomics and machine learning offer opportunities to improve dietary pattern assessment and reduce exposure misclassification (15,17). Integration of objective biomarkers with traditional dietary instruments may substantially strengthen causal inference and advance precision nutrition research (1,5).